NASDAQ: SNCE - Science 37 Holdings, Inc.

半年間の収益性: 0%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Science 37 Holdings, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.

さらに詳しく
The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2020-11-20
ISIN US8086441081
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.science37.com
Цена ао 5.75
1日あたりの価格変動: 0% (5.75)
週ごとの価格変動: 0% (5.75)
月ごとの料金変更: 0% (5.75)
3ヶ月間の価格変動: 0% (5.75)
半年間の価格変動: 0% (5.75)
年間の価格変動: 0% (5.75)
3年間の価格推移: +5.89% (5.43)
年初からの価格変動: 0% (5.75)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0.6789 10
P/BV 0.489 10
P/E 0 0
EV/EBITDA 0.4243 10
合計: 6.25

効率

名前 意味 学年
ROA, % -26.33 0
ROE, % -46.57 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.0093 10
合計: 9.8

成長の衝動

名前 意味 学年
収益性 Revenue, % 154.27 10
収益性 Ebitda, % 426.07 10
収益性 EPS, % 11478.95 10
合計: 10
さらに詳しく

機関 音量 共有, %
Redmile Group, LLC 990412 0.83
Kent Lake Capital, LLC 278560 0.23
Glynn Capital Management Llc 176992 0.15
Russell Investments Group, Ltd. 169696 0.14
Vanguard Group Inc 160367 0.13
Alphabet Inc. 160364 0.13
MIC Capital Management UK LLP 117295 0.1
Alyeska Investment Group, L.P. 88319 0.07
Citadel Advisors Llc 67631 0.06
Samsara BioCapital, LLC 45000 0.04



スーパーバイザー 役職 支払い 生年
Mr. David Coman CEO & Director 796.13k 1970 (55 年)
Ms. Christine A. Pellizzari J.D. Chief Legal & Human Resources Officer and Secretary 521.58k 1968 (57 年)
Ms. Darcy Forman Chief Delivery Officer 550.58k 1976 (49 年)
Mr. Mike Zaranek Chief Financial Officer N/A 1971 (54 年)
Irena Lambridis VP and Head of Quality Assurance & Compliance N/A
Ms. Margie Gimbel Kooman Vice President of Marketing & Communications N/A
Mr. Drew Bustos Chief Strategy & Marketing Officer N/A
Mr. Jonathan Cotliar M.D. Chief Medical Officer 486.6k 1972 (53 年)
Mr. Michael Shipton Chief Commercial Officer N/A 1972 (53 年)
Mr. Tyler Van Horn VP of Corporate Strategy & Chief of Staff N/A

住所: United States, Research Triangle Park. NC, 800 Park Offices Drive - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.science37.com